What we do Medi Caps Ltd is India’s second-largest manufacturer of empty hard gelatin capsules for pharmaceutical dosage medicines, now diversified into real estate. |
Founded in 1,983 |
Market share Second-largest player in India’s empty hard gelatin capsule manufacturing segment. |
Problem solved Provides high-quality empty capsules for oral medicines ensuring dosage accuracy and manufacturing reliability. |
Top clients or who we serve Pharmaceutical companies like Dr. Reddy's, Lupin, Aristo Pharmaceuticals; primarily B2B customers. |
Key management Mr. Ramesh Chandra Mittal (Chairman), Mr. Alok K. Garg (Managing Director); experienced leadership. |
Our journey and innovations Incorporated in 1983; expanded capacities in 1995 and 2002; ISO 9002 certified; shifted to real estate in 2019 after ceasing capsule manufacturing. |
Where we operate India (manufacturing and real estate), exports to China, Thailand, Dubai, Malaysia, South Africa, Philippines. |
Top products or what we offer Empty hard gelatin capsules (multiple sizes); now also offers real estate development through Medi Caps Business Park. |
Top brands Not applicable - no consumer brands; known for capsules in pharma B2B and Medi Caps Business Park project in real estate. |
Raw materials needed Gelatin and related pharmaceutical-grade materials for capsule manufacturing. |
Raw materials supplier Not specified in the information provided. |
Recurring vs cyclical contribution Pharma segment revenue declined; real estate segment generates growing but smaller revenue; overall mixed revenue streams. |
Our industry position Strong historic standing in pharma capsules; transitioned focus to real estate after ceasing pharma manufacturing. |
Financial highlights FY 2024-25 standalone revenue INR 2.98 crore with net profit INR 0.56 crore; consolidated revenue INR 28.21 crore with net loss INR 0.57 crore. |
Geographical revenue split Domestic revenue from India; exports to select Asian and African countries. |
Order book Details not disclosed; new projects include Medi Caps Business Park in real estate. |
Whats driving growth Pivot to real estate development and residual pharma operations. |
Our future plans Focus on growing real estate business, leveraging existing land assets in Indore area. |
Our green promise No specific ESG initiatives disclosed currently. |
Our people and values Committed to corporate governance and sustainability; maintained small employee base post manufacturing closure. |
Key challenges ahead Transition away from pharma manufacturing impacts revenue; building real estate business. |
Interesting facts Second-largest capsule manufacturer in India before pivoting to real estate post-2019. |
Risks and strategy Diversification risk managed by developing real estate projects; focus on governance and compliance. |
